Evidence map›Paper›PMID 21220680›Full record

SynthesisArchives of neurology2011

Meta-analysis of the association between variants in SORL1 and Alzheimer disease.

Christiane Reitz, Rong Cheng, Ekaterina Rogaeva, Joseph H Lee, Shinya Tokuhiro, Fanggeng Zou, Karolien Bettens, Kristel Sleegers, Eng King Tan, Ryo Kimura and 22 more

Erratum issuedOpen access · bronzeAbstract readComparative StudyMeta-Analysis
In one paragraph

Synthesis in Archives of neurology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 95 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 6 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 6 syntheses or guidelines pooled it, 166 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. A familial missense variant in the Alzheimer's Disease genebioRxiv : the preprint server for biology · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Endophenotypic effects of theFrontiers in aging neuroscience · 2022
    Article
  18. Article
  19. Article
  20. Review

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

32 authors at 1 institution in 1 country.

Christiane ReitzThe Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Rong Cheng
Ekaterina Rogaeva
Joseph H Lee
Shinya Tokuhiro
Fanggeng Zou
Karolien Bettens
Kristel Sleegers
Eng King Tan
Ryo Kimura
Nobuto Shibata
Heii Arai
M Ilyas Kamboh
Jonathan A Prince
Wolfgang Maier
Matthias Riemenschneider
Michael Owen
Denise Harold
Paul Hollingworth
Elena Cellini
Sandro Sorbi
Benedetta Nacmias
Masatoshi Takeda
Margaret A Pericak-Vance
Jonathan L Haines
Steven Younkin
Julie Williams
Christine van Broeckhoven
Lindsay A Farrer
Peter H St George-Hyslop
Richard Mayeux
Genetic and Environmental Risk in Alzheimer Disease 1 Consortium
Columbia University · US

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI JOHN MORRIS · 1985 to 2026
$69.5M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 1985 to 2019
$52.1M
The natural history of AB accumulation in preclinical ADP01AG026276 · NIA · WASHINGTON UNIVERSITY · PI SCHINDLER, SUZANNE ELIZABETH · 2005 to 2025
$49.5M
TREATMENT OF DEPRESSION IN ALZHEIMER'S DISEASEP50AG005133 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BECKER, JAMES T. · 1985 to 2019
$43.0M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI BU, GUOJUN · 1999 to 2018
$36.9M
The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family-Based Study (FBS)U24AG056270 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gary Wayne Beecham, TATIANA M. FOROUD · 2017 to 2026
$31.4M
Neuropathology CoreP30AG013846 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOWALL, NEIL W. · 1996 to 2020
$29.1M
VASCULAR FACTORS AND MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASEP01AG007232 · NIA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI LUCHSINGER, JOSE ALEJANDRO · 1989 to 2008
$21.7M
GENETIC EPIDEMIOLOGICAL STUDIES OF ALZHEIMERS DISEASER01AG009029 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARRER, LINDSAY A. · 1991 to 2007
$14.7M
Genetic Epidemiology of Alzheimer's Disease in HispanicsR37AG015473 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAYEUX, RICHARD P · 2004 to 2013
$10.8M
Epidemiology of Biomarkers of Risk and Progression in LOADR01AG037212 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAYEUX, RICHARD P, SCHUPF, NICOLE · 2010 to 2015
$10.1M
CIHRHoward Hughes Medical InstituteMedical Research Council G0300429Medical Research Council MC_G1000734NIA NIH HHS AG028555NIA NIH HHS AG030653NIA NIH HHS AG05133NIA NIH HHS AG08724NIA NIH HHS AG08861NIA NIH HHS K23 AG034550NIA NIH HHS K23AG034550NIA NIH HHS P01 AG003991NIA NIH HHS P01 AG007232NIA NIH HHS P01 AG026276NIA NIH HHS P01-AG026276NIA NIH HHS P01-AG03991NIA NIH HHS P01-AG07232NIA NIH HHS P30 AG013846NIA NIH HHS P30-AG13846NIA NIH HHS P50 AG005133NIA NIH HHS P50 AG005681NIA NIH HHS P50 AG016574NIA NIH HHS P50-AG05681NIA NIH HHS P50-AG16574NIA NIH HHS R01 AG008724NIA NIH HHS R01 AG009029NIA NIH HHS R01 AG016208NIA NIH HHS R01 AG017173NIA NIH HHS R01 AG018023NIA NIH HHS R01 AG018732NIA NIH HHS R01 AG025259NIA NIH HHS R01 AG028555NIA NIH HHS R01 AG030653NIA NIH HHS R01 AG037212NIA NIH HHS R01 AG041797NIA NIH HHS R01-AG09029NIA NIH HHS R01-AG16208NIA NIH HHS R01-AG17173NIA NIH HHS R01-AG18023NIA NIH HHS R01-AG25259NIA NIH HHS R37 AG015473NIA NIH HHS R37-AG15473NIA NIH HHS U24 AG021886NIA NIH HHS U24 AG056270Wellcome Trust 081864Wellcome Trust 089703Wellcome Trust GR082604MA
6 · The paper itself

Abstract

objectiveTo reexamine the association between the neuronal sortilin-related receptor gene (SORL1) and Alzheimer disease (AD).

designComprehensive and unbiased meta-analysis of all published and unpublished data from case-control studies for the SORL1 single-nucleotide polymorphisms (SNPs) that had been repeatedly assessed across studies.

settingAcademic research institutions in the United States, the Netherlands, Canada, Belgium, the United Kingdom, Singapore, Japan, Sweden, Germany, France, and Italy.

participantsAll published white and Asian case-control data sets, which included a total of 12,464 cases and 17,929 controls.

main outcome measuresAlzheimer disease according to the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) and the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (now known as the Alzheimer's Association).

resultsIn the white data sets, several markers were associated with AD after correction for multiple testing, including previously reported SNPs 8, 9, and 10 (P < .001). In addition, the C-G-C haplotype at SNPs 8 through 10 was associated with AD risk (P < .001). In the combined Asian data sets, SNPs 19 and 23 through 25 were associated with AD risk (P < .001). The disease-associated alleles at SNPs 8, 9, and 10 (120,873,131-120,886,175 base pairs [bp]; C-G-C alleles), at SNP 19 (120,953,300 bp; G allele), and at SNPs 24 through 25 (120,988,611 bp; T and C alleles) were the same previously reported alleles. The SNPs 4 through 5, 8 through 10, 12, and 19 through 25 belong to distinct linkage disequilibrium blocks. The same alleles at SNPs 8 through 10 (C-G-C), 19 (G), and 24 and 25 (T and C) have also been associated with AD endophenotypes, including white matter hyperintensities and hippocampal atrophy on magnetic resonance imaging, cerebrospinal fluid measures of amyloid β-peptide 42, and full-length SORL1 expression in the human brain.

conclusionThis comprehensive meta-analysis provides confirmatory evidence that multiple SORL1 variants in distinct linkage disequilibrium blocks are associated with AD.

Indexed as

AllelesAlzheimer DiseaseCase-Control StudiesGenetic VariationHumansLDL-Receptor Related ProteinsMembrane Transport ProteinsNerve Tissue ProteinsPolymorphism, Single NucleotideLDL-Receptor Related ProteinsMembrane Transport ProteinsNerve Tissue ProteinsSORL1 protein, human

Identifiers

PMID21220680
PMCPMC3086666
OpenAlexW2143884110

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.